1. Беленков Ю.Н., Привалова Е.В., Каплунова В.Ю., Фомин А.А. Гипертрофическая кардиомиопатия, особенности течения при длительном наблюдении // Тер. архив. – 2008. – №8. – С. 18-25.

2. Наследственные болезни: национальное руководство / под ред. акад. РАМН Н.П. Бочкова / М.: ГЭОТАР – Медиа, 2012. – 936 с.

3. American College of Cardiology / Europian Society of Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert RE-HEALTH JOURNAL №2.2 (6)’ 2020 20 Consensus Documents and the Europian Society of Cardiology Committee for Practic Guidelines // Eur. Heart. J. – 2014. - №24. – pp.1965-1991.

4. Nishimura R.A., Holmes D.R. Hypertrophic Obstructive Cardiomyopathy // N. Engl. J. Med. – 2014. – V. 13. – pp. 1320-1327.

5. Maron B.J., Lipson L.C., Roberts W.C. «Malignant» hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature deaths // Am. J. Cardiol. – 2008. – V. 41. – pp. 1133-1140.

6. Porter T.R. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography // J. Amer. Society of Echocardiog. – 2014. – V.27. - №8. – pp.797-810.

7. Lang R.M. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the Europian Association of Cardiovascelar Imaging // J. Amer. Society of Echocardiog. – 2015. – V.28. - №1. – pp.1-39.